Stryker Corp (SYK.N)
23 Feb 2018
* STRYKER CROSSES THE 95% THRESHOLDS IN VEXIM AND ANNOUNCES ITS INTENTION TO FILE A PROPOSED PUBLIC BUY-OUT OFFER FOLLOWED BY A SQUEEZE-OUT FOR THE OUTSTANDING SHARES OF VEXIM
* CROSSED 95 PCT THRESHOLDS IN VEXIM & INTENDS TO FILE A PROPOSED PUBLIC BUY-OUT OFFER FOLLOWED BY A SQUEEZE-OUT FOR OUTSTANDING SHARES OF VEXIM
* REG-STRYKER DECLARES A $0.47 PER SHARE QUARTERLY DIVIDEND Source text for Eikon: Further company coverage:
* Q4 EARNINGS PER SHARE VIEW $1.95 -- THOMSON REUTERS I/B/E/S
BRIEF-Stryker Expects 2017 Adj Net Earnings Per Diluted Share To Be Toward High End Of Previous Range Of $6.45-$6.50
* STRYKER - EXPECT 2017 ADJUSTED NET EARNINGS PER DILUTED SHARE TO BE TOWARD HIGH END OF PREVIOUSLY ANNOUNCED RANGE OF $6.45 TO $6.50
* STRYKER ANNOUNCES MR. HOWARD COX JR WILL RETIRE FROM BOARD OF DIRECTORS
Medical device maker Stryker Corp said on Thursday it would buy Entellus Medical Inc for $662 million, adding heft to its ear, nose and throat (ENT) business.
Dec 7 Medical device maker Stryker Corp said on Thursday it would buy Entellus Medical Inc for $662 million, adding heft to its ear, nose and throat (ENT) business.
Dec 7 Medical device maker Stryker Corp said on Thursday it would buy medical technology company Entellus Medical Inc in a deal valued at about $662 million, adding heft to its ENT business.
* ENTELLUS MEDICAL ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION FOR A PURCHASE PRICE OF $24.00 PER SHARE IN CASH
|Olympus Corp (7733.T)||¥4,140||+20.00|
|Johnson & Johnson (JNJ.N)||$132.02||+2.11|
|Zimmer Biomet Holdings Inc (ZBH.N)||$118.85||+1.27|
|Smith & Nephew plc (SN.L)||1,265.00||-5.00|
|Hill-Rom Holdings, Inc. (HRC.N)||$84.06||+0.62|
|CONMED Corporation (CNMD.OQ)||$60.67||+0.26|
|NuVasive, Inc. (NUVA.OQ)||$47.86||+0.88|
|Globus Medical Inc (GMED.N)||$47.91||-0.57|
|Medtronic PLC (MDT.N)||$80.39||-0.02|
|Terumo Corp (4543.T)||¥5,470||+10.00|